Constructing "best interests": genetic testing of children in families with hypertrophic cardiomyopathy

Els Geelen1, Ine Van Hoyweghen, Pieter A Doevendans

  • 1Department of Health, Ethics and Society, Maastricht University, Maastricht, The Netherlands. e.geelen@maastrichtuniversity.nl

Insights

The "best interest" of a child undergoing genetic testing is a dynamic, long-term family process, not an immediate decision. Parents and professionals learn and adapt meanings of best interest over time.

Area of Science:

  • Pediatric Genetics
  • Bioethics
  • Family Studies

Background:

  • Genetic testing guidelines for children now emphasize parental and professional judgment of the child's
  • best interest
  • over the child's autonomous choice.
  • The concept of
  • best interest
  • encompasses therapeutic, psychological, and social factors.

Purpose of the Study:

  • To explore how parents and professionals practically determine a child's
  • best interest
  • in genetic testing scenarios.
  • To understand the long-term construction of
  • best interest
  • within extended families.

Main Methods:

  • Qualitative study involving six extended families undergoing genetic testing for hypertrophic cardiomyopathy.
  • In-depth interviews with 57 family members over 3.5 years, with multiple interviews for many participants.

Main Results:

  • A child's
  • best interest
  • is established through ongoing, long-term processes within the wider family and kin network.
  • The definition and application of
  • best interest
  • are continuously considered and revised within this family context.

Conclusions:

  • A child's
  • best interest
  • in genetic testing should not be viewed as a singular, immediate agreement between parents and professionals.
  • Professionals and parents engage in reflective learning processes to develop evolving understandings of
  • best interest
  • amidst diverse family dynamics.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...